The presenter states, "I'm definitely not investing in this company until I see growth turn positive again." He also notes that he won't consider the company until guidance improves, suggesting he does not recommend buying it at the current time.
This video analyzes a stock pick from Dylan Jovine, focusing on Avantor Incorporated (AVTR), a company that supplies lab equipment and chemicals. The presenter discusses Jovine's claims of massive potential gains driven by the Biosecure Act, which aims to reduce reliance on Chinese biotech suppliers. The video examines Avantor's business, its recent struggles, its revival plan, and its current valuation, offering a bull and bear case for the stock.
